NVCR Novocure Limited -11.66-0.49 (-4.0%)
NVCR Novocure Limited -12.21+0.15 (+1.2%)
NVCR Novocure Limited -14.30+2.56 (+21.8%)
NVCR Novocure Limited -10.98-1.55 (-12.4%)
After Hours:0.00-10.98 (-100.0%)
NVCR Novocure Limited -13.46+2.96 (+28.2%)
After Hours Gainer
NVCR Novocure Limited -10.50+0.03+0.3%
After Hours:13.60+3.10 (+29.5%)
U.S. FDA Approves Novocure's Optune Pax for the Treatment of Locally Advanced Pancreatic Cancer
Business WireWed, 11-Feb 5:54 PM
